End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
Jun. 01 | AB-Biotics, S.A. acquired Alifarm S.A. for EUR 3.5 million. | CI |
Nov. 07 | Kaneka Europe Holding Company N.V. completed the acquisition of 18.21% stake in AB-Biotics, S.A. | CI |
Sales 2017 | 7.72M 8.33M | Sales 2018 | 12.59M 13.59M | Capitalization | 38.75M 41.82M |
---|---|---|---|---|---|
Net income 2017 | - 0 | Net income 2018 | 1M 1.08M | EV / Sales 2017 | 2.22 x |
Net cash position 2017 | 1.86M 2M | Net cash position 2018 | 2.44M 2.63M | EV / Sales 2018 | 2.88 x |
P/E ratio 2017 |
-21.2
x | P/E ratio 2018 |
31.7
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 31.56% |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 04-04-22 | |
Founder | - | 04-04-22 | |
Shinji Mizusawa
BRD | Director/Board Member | - | 18-07-01 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 69.57M | |
-6.65% | 12.54B | |
+82.29% | 4.14B | |
-14.23% | 2.34B | |
-23.73% | 2.51B | |
-19.45% | 1.66B | |
+32.37% | 1.15B | |
+7.42% | 840M | |
-11.75% | 548M | |
-34.49% | 466M |